JIGFX
Price
$66.16
Change
-$0.02 (-0.03%)
Updated
Jun 16 closing price
Net Assets
4.6B
VTMNX
Price
$23.24
Change
-$0.05 (-0.21%)
Updated
Jun 16 closing price
Net Assets
317.3B
Interact to see
Advertisement

JIGFX vs VTMNX

Header iconJIGFX vs VTMNX Comparison
Open Charts JIGFX vs VTMNXBanner chart's image
JIGFX vs VTMNX Comparison Chart in %
View a ticker or compare two or three
VS
JIGFX vs. VTMNX commentary
Jun 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JIGFX is a Hold and VTMNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTMNX has more cash in the bank: 317B vs. JIGFX (4.6B). VTMNX pays higher dividends than JIGFX: VTMNX (2.61) vs JIGFX (1.13). JIGFX was incepted earlier than VTMNX: JIGFX (17 years) vs VTMNX (25 years). JIGFX (0.81) is less costly to investors than VTMNX (0.03). JIGFX is a more actively managed with annual turnover of: 42.00 vs. VTMNX (4.00). JIGFX has a lower initial minimum investment than VTMNX: JIGFX (2500) vs VTMNX (5000000). JIGFX (29.70) and VTMNX (28.99) have marching annual gain over last year. JIGFX return over 5 years is better than : 59.45 vs. VTMNX (41.43).
JIGFXVTMNXJIGFX / VTMNX
Total Expense Ratio0.810.032,700%
Annual Report Gross Expense Ratio0.810.032,700%
Fund Existence17 years25 years-
Gain YTD15.20115.99595%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.6B317B1%
Annual Yield % from dividends1.132.6143%
Returns for 1 year29.7028.99102%
Returns for 3 years59.5357.36104%
Returns for 5 years59.4541.43143%
Returns for 10 years223.28118.02189%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MKL1879.8525.80
+1.39%
Markel Group
AVNT37.670.13
+0.35%
Avient Corp
NGVC30.56-0.09
-0.29%
Natural Grocers BY Vitamin Cottage
CVRX4.87-0.11
-2.21%
CVRx
PBM3.15-0.15
-4.55%
Psyence Biomedical Ltd.